Willie Fussell, DO
Interventional Pain Medicine · Albany, GANPI 1740377787
Payments from drug & device makers
What this record shows
Medtronic accounts for 67.0% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $2,952, 9.8 times the $300 reported in 2019.
Across 94 payments — averaging $60.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Nevro Corp.$718
- Boston Scientific$502
- Globus Medical$99
- Amgen$70
- Abbott$68
- plus $428 from 13 others
What the payments were for
- Travel & lodging$2,57845%
- Food & beverage$3,13355%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 37 | $3,827 |
| Nevro Corp. | 20 | $718 |
| Boston Scientific | 7 | $502 |
| Globus Medical | 4 | $99 |
| Amgen(2 entities) | 4 | $70 |
| Abbott | 3 | $68 |
| GRT US Holding, Inc. | 4 | $65 |
| Organogenesis Inc. | 1 | $55 |
| Averitas Pharma Inc. | 2 | $52 |
| Almatica Pharma LLC | 2 | $45 |
| Medline Industries LP | 2 | $39 |
| Stimwave Technologies Incorporated | 1 | $32 |
| Johnson & Johnson | 1 | $28 |
| CGG Medical Inc | 1 | $23 |
| Nalu Medical, Inc. | 1 | $22 |
| Vertex | 1 | $20 |
| Pacira Therapeutics, Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| AbbVie | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KYPHON EXPRESS II KYPHOPAK TRAY$1,921
- INTELLIS ADAPTIVESTIM$816
- GENERAL PAIN MANAGEMENT$337
- Senza$250
- INCEPTIV$134
- INTELLIS$104
How this compares
$5,711 in reported general payments places this provider in the 55th percentile of 129 interventional pain medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 291 | $4,751 |
| Gabapentin | 119 | $1,244 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 48 | $526 |
| Duloxetine Hcl | 19 | $454 |
| Diclofenac Sodium | 23 | $415 |
| Tramadol Hcl | 69 | $339 |
| Baclofen | 38 | $216 |
| Nortriptyline Hcl | 14 | $118 |
| Meloxicam | 24 | $94 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Albany
- Emmanuel GageBrunswick$602K
- Jordan TateJasper$540K
- Christopher BovinetBrunswick$338K
- David RosenfeldCovington$249K
- Nathan NeufeldNewnan$171K
- Ryan BudwanyLawrenceville$123K
- Alexandra MoreiraAtlanta$79K
- Sushanth BodaNewnan$55K
- Christopher AndrianoStockbridge$41K
- Guensley DelvaWaycross$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.